July 18, 2022 by MMR
consumer health care, GSK, Haleon
Leading Headlines, Supplier News

WARREN, N.J. — Haleon has been launched as an independent consumer health company following its spin-off from GSK. Trading of shares in the newly listed business began July 18 on the London Stock Exchange, where CEO Brian McNamara presided over the day’s ceremonial opening. Trading on the New York Stock Exchange is set to begin
April 1, 2022 by MMR
GlaxoSmithKline, GSK, Rachel Marler
Leading Headlines, People, Retail News

WARREN, N.J. — GlaxoSmithKline (GSK) announced Friday the appointment of Rachel Marler as the new Chief Customer Officer, US. In her role, Marler will lead GSK Consumer Health’s customer engagement efforts to build strong, trusting retailer partnerships and deliver compelling category and shopper healthcare experiences across the customer channels. She is a U.S. leadership team
March 3, 2022 by MMR
GSK, Haleon
Supplier News

LONDON — Haleon will be the name of the new company resulting from the proposed spin-off of GlaxoSmithKline plc’s (GSK) Consumer Healthcare business in mid-2022. Haleon (pronounced “Hay-Lee-On”) merges “hale,” an old English word that means “in good health,” and the Greek “leon,” which is associated with strength. The new brand identity was developed with
July 26, 2021 by MMR
flu vaccine, GSK, influenza vaccine
Leading Headlines, Supplier News

PHILADELPHIA — GSK has started shipping its quadrivalent influenza vaccines to U.S. health care providers and pharmacies for the 2021-22 flu season. This immediately follows a licensing and lot-release approval from the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research. GSK expects to distribute more doses than it has in any
July 23, 2021 by MMR
Brian McNamara, GSK, GSK chairman Sir Jonathan Symonds, GSK Consumer Healthcare
Leading Headlines, Supplier News

LONDON — Brian McNamara has been appointed CEO designate of the new, independent consumer health care company that will be spun off from GSK in 2022. As set out at GSK’s Investor Update on 23 June 2021, subject to approval from shareholders, the separation of Consumer Health care will be by way of a
February 17, 2021 by MMR
GSK, GSK Consumer Healthcare, Tums, Tums Naturals
Supplier News

WARREN, N.J. — GSK Consumer Healthcare has launched Tums Naturals, a new heartburn relief medicine that is free-from artificial flavors and dyes. Like all the brands’ products, the company says, the new TUMS Naturals deliver fast and powerful multi-symptom relief from the discomforts of burning in the chest, acid indigestion, sour and upset stomach. Research
January 14, 2019 by MMR
GlaxoSmithKline Plc, GSK, Pfizer Inc.
2019, Issue 01-14-2019, Issues
WARREN, N.J. — Pfizer Inc. and GlaxoSmithKline PLC (GSK) have entered into an agreement that will create a premier global consumer health care company with robust iconic brands. The boards of directors of both companies have unanimously approved the transaction under which Pfizer will contribute its consumer health care business to GSK’s existing consumer health
March 16, 2016 by MMR
Children’s Flonase Allergy Relief, GlaxoSmithKline Consumer Healthcare, GSK, over-the-counter
Supplier News

WARREN, N.J. — GlaxoSmithKline Consumer Healthcare has introduced Children’s Flonase Allergy Relief just in time for spring. Children’s Flonase is an over-the-counter nasal spray that has been approved to treat allergy symptoms including runny nose, sneezing, itchy nose, congestion, and itchy, watery eyes. The company says that the product is a safe, non-habit-forming way for